𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production and characterization of xenogeneic antisera to tumor-associated antigen(s)

✍ Scribed by Rishab K. Gupta; Dr. Hulbert K. B. Silver; Donald L. Morton


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
836 KB
Volume
13
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Tumor‐associated antigen(s) from a specimen of human malignant melanoma and from spent culture medium of a melanoma cell line were extracted and purified. The incidence of antibody activity to these antigens, in sera from cancer patients with neoplasms of various histologic types, was higher (65–83%) than normal donors' (19–25%) by the complement fixation assay. These purified antigens were then used to raise antisera in rabbits and sheep. After absorption with various human normal tissues, these antisera reacted against melanoma, sarcoma, and carcinoma extracts, but not against human normal liver, skin, or muscle extracts. However, the antisera showed reactivity against a human fetal homogenate. Results indicate that the xenogeneic antisera contained antibodies to fetal antigens and to tumor‐associated antigen(s). Xenogeneic antisera could be used to purify tumor‐associated antigens and oncofetal antigen(s) from crude extracts by affinity chromatography.


📜 SIMILAR VOLUMES


Membrane-associated antigens on tumor ce
✍ Michael U. Schneider; Marita Troye; Staffan Paulie; Peter Perlmann 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 702 KB

## Abstract An antiserum was raised in rabbits by immunization with a human tumor cell line, T‐24, derived from transitional cell carcinoma (TCC) of the urinary bladder. The specificity of the IgG fraction was assessed by antibody‐dependent cellular cytotoxicity (ADCC), using purified blood lymphoc

Evaluation of the humoral response of gl
✍ Alec Martin-Achard; Annie-Claire Diserens; Nicolas de Tribolet; Stefan Carrel 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 541 KB

## Abstract Cytotoxic antibodies against glioblastoma‐associated antigen(s) have been sought for in glioma patient sera. Complement‐dependent cytotoxicity (CDC) and antibody‐dependent cell‐mediated cytotoxicity (ADCC) assays were used to test sera from 80 patients using ^51^Cr labelled target cells

Characterization of a 90-100 kDa tumor-a
✍ David M. Euhus; Rishab K. Gupta; Donald L. Morton 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 694 KB

## Abstract Using allogeneic antibody, we previously described a highmolecular‐weight glycoprotein in the urine of 68% of melanoma patients. This glycoprotein has been termed urinarytumor‐associated antigen (U‐TAA). A murine monoclonal antibody (MAb) specific for U‐TAA (AD1‐40F4) has been developed